1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
Ophthalmic Drugs Market - Global Opportunity Analysis and Industry Forecast, 2017-2023

Ophthalmic Drugs Market - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • November 2017
  • 351 pages
  • ID: 5228632
  • Format: PDF
  • By Allied Market Research


Table of Contents

Ophthalmic Drugs Market by Indication (Dry Eye, Glaucoma, Infection/Inflammation/Allergy, Retinal Disorders, and Others), Type (Prescription Drugs, and Over-the-Counter Drugs), Dosage Form (Liquid Ophthalmic Drug Forms, Solid Ophthalmic Drug Forms, Semisolid Ophthalmic Drug Forms, Multicompartment Drug Delivery Systems, and Other Ophthalmic Drug Forms), Technology (Biologics, Cell Therapy, Gene Therapy, Drug Delivery, Small Molecule, and Others), Distribution Channel (Hospital Pharmacies, Drug Stores, Online Pharmacies, and Others), and Therapeutic Class (Anti-glaucoma, Anti-infection, Anti-inflammatory, and Anti-allergy) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Ophthalmic drugs are preparations used for the treatment of eye diseases and disorders such as cataract, glaucoma, color blindness, diabetic macular edema, CMV retinitis, and age-related macular degeneration. The ophthalmic drugs market is witnessing significant growth, due to increase in prevalence of eye disorders and rise in use of combination therapies for treatment of ophthalmic disorders, especially glaucoma. Combination therapies have various advantages over traditional medication such improvement in patient compliance and efficacy. Moreover, surge in prevalence of ophthalmic disorders, rise in geriatric population globally, and change in demographics fuel the ophthalmic drugs market growth. The global ophthalmic drugs market was valued at $29,613 million in 2016, and is expected to reach $42,663 million by 2023, registering a CAGR of 5.3% from 2017 to 2023.

The ophthalmic drugs market is segmented based on indication, type, distribution channel, dosage form, technology, therapeutic class, and geography. Depending on indication, the market is divided into dry eye, glaucoma, infection/inflammation/allergy, retinal disorders, and others. On the basis of type, the market is bifurcated into prescription drugs and over-the-counter drugs. By distribution channel, it is categorized into hospital pharmacies, online pharmacies, drug stores, and others. According to dosage form, it is classified into liquid ophthalmic drug forms, semisolid ophthalmic drug forms, solid ophthalmic drug forms, multicompartment drug delivery systems, and other ophthalmic drug forms. As per technology, the market is segmented into biologics, cell therapy, gene therapy, drug delivery, small molecule, and others. Based on therapeutic class, it is classified into anti-inflammatory drugs, anti-infective drugs, anti-glaucoma drugs, and anti-allergy drugs. Based on geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

As per ophthalmic drugs market analysis, in the recent years, Asia-Pacific reported significant growth in the ophthalmic drugs market, owing to steady increase in the prevalence of glaucoma in the Asian population. In addition, increase in the number of people suffering from primary angle-closure glaucoma in Japan, China, and South Korea supplement this growth further.

The study provides an in-depth analysis of the global ophthalmic drugs market with the current trends and future estimations to elucidate the imminent investment pockets.
Comprehensive analysis of the factors that drive and restrict the market growth is provided.
Comprehensive quantitative analysis of the industry is provided from 2016 to 2023 to assist stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the key segments of the industry helps in understanding the trends in types and technologies globally.
Key players and their strategies are provided to understand the competitive outlook of the industry.


By Indication
Dry Eye
Retinal Disorders
Wet Age-related Macular Degeneration
Dry Age-related Macular Degeneration
Diabetic Retinopathy

By Type
Prescription Drugs
Over-the-Counter Drugs

By Dosage Form
Liquid Ophthalmic Drug Forms
Solid Ophthalmic Drug Forms
Semisolid Ophthalmic Drug Forms
Multicompartment Drug Delivery Systems
Other Ophthalmic Drug Forms

By Technology
Cell Therapy
Gene Therapy
Drug Delivery
Small Molecule

By Distribution Channel
Hospital Pharmacies
Drug Stores
Online Pharmacies

By Therapeutic Class

By Geography
North America
Rest of Europe
South Korea
Rest of Asia-Pacific
South Africa
Saudi Arabia
Rest of LAMEA

Santen Pharmaceutical Co., Ltd.
Bausch & Lomb Inc. (Valeant Pharmaceuticals International, Inc.)
Shire Plc
Alcon (Novartis)
Genentech, Inc.
Allergan, Plc
Sun Pharmaceutical Industries Limited
Actavis Generics (Teva Pharmaceutical Industries Ltd.)
Regeneron Pharmaceuticals, Inc.
Pfizer Inc.

The other players in the value chain include (profiles not included in the report)
Abbott Medical Optics, Inc.
Carl-Zeiss AG
Ellex Medical Lasers Ltd.
Essilor International S.A.
Hoya Corporation
Insight Vision Inc.
Nidek Co. Ltd.
Novagali Pharma S A
Topcon Corporation
Ziemer Ophthalmic Systems AG

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
15% Off


  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Rocklatan (netarsudil and latanoprost ophthalmic solution) - Drug Insight and Market Forecast - 2030

Rocklatan (netarsudil and latanoprost ophthalmic solution) - Drug Insight and Market Forecast - 2030

  • $ 2750
  • February 2020

Overview“Rocklatan (netarsudil and latanoprost ophthalmic solution) - Drug Insight and Market Forecast – 2030” report outlays comprehensive insights of the product indicated for the treatment of ...

Rhino-Conjunctivitis - Pipeline Review, H2 2019

Rhino-Conjunctivitis - Pipeline Review, H2 2019

  • $ 2000
  • December 2019

Rhino-Conjunctivitis - Pipeline Review, H2 2019SummaryThe latest Pharmaceutical and Healthcare disease pipeline guide Rhino-Conjunctivitis - Pipeline Review, H2 2019, provides an overview of the Rhino ...

Ophthalmic Drugs Contract Manufacturing Market, 2020-2030

Ophthalmic Drugs Contract Manufacturing Market, 2020-2030

  • $ 4899
  • January 2020

INTRODUCTIONOphthalmic diseases, such as age-related macular degeneration, cataract, diabetic retinopathy, dry eye and glaucoma, are considered among the leading causes of vision loss across the globe. ...

Consumer Health in South Africa $ 2650 February 2020

Global Artificial Tears Industry $ 5450 February 2020

Consumer Health in Romania $ 2650 October 2019

Download Unlimited Documents from Trusted Public Sources

Global Ophthalmic Solution Forecast

  • February 2020
    4 pages
  • Ophthalmic Solu...  

    Eye Disease  


  • World  

View report >

Global Ophthalmic Solution Industry - Forecast

  • December 2019
    5 pages
  • Ophthalmic Solu...  

    Eye Disease  


  • World  

View report >

Ophthalmic Solution Industry in the UK

  • June 2019
    9 pages
  • Ophthalmic Solu...  


  • United Kingdom  

View report >


Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on